Answer
Secukinumab (Cosentyx) is indicated for adults with active moderate to severe hidradenitis suppurativa (acne inversa) who have had an inadequate response to conventional systemic HS therapy.
Sources for this answer
- Cosentyx 150mg and 300mg solution for injection in pre-filled syringe and pre-filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 29Document updated
Sources checked